Efficacy And Safety of Setmelanotide In Acquired Hypothalamic Obesity: Results From A Double-blind, Multicenter, Placebo-controlled, Randomized Phase 3 Trial

Authors
Category Primary study
ConferenceENDO 2025
Year 2025
This article has no abstract
Epistemonikos ID: 1b8b3585a6f37ade8890c87c909ae804595ed5b3
First added on: Nov 28, 2025